Related references
Note: Only part of the references are listed.Liquid biopsies in patients with diffuse glioma
Myron G. Best et al.
ACTA NEUROPATHOLOGICA (2015)
Adapting the drivers to the road: a new strategy for cancer evolution?
M. Touat et al.
ANNALS OF ONCOLOGY (2015)
Detection, Characterization, and Inhibition of FGFR-TACC Fusions in IDH Wild-type Glioma
Anna Luisa Di Stefano et al.
CLINICAL CANCER RESEARCH (2015)
Brain Tumor Mutations Detected in Cerebral Spinal Fluid
Wenying Pan et al.
CLINICAL CHEMISTRY (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Identification of microRNAs as novel biomarkers for glioma detection: A meta-analysis based on 11 articles
Shengtao Qu et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Toward precision medicine in glioblastoma: the promise and the challenges
Michael D. Prados et al.
NEURO-ONCOLOGY (2015)
Diagnostic Value of Plasma and Urinary 2-Hydroxyglutarate to Identify Patients With Isocitrate Dehydrogenase-Mutated Glioma
Giuseppe Lombardi et al.
ONCOLOGIST (2015)
Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity
Mona Meyer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
Nicholas McGranahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
Huilin Shao et al.
NATURE COMMUNICATIONS (2015)
Belonging to a network-microRNAs, extracellular vesicles, and the glioblastoma microenvironment
Jakub Godlewski et al.
NEURO-ONCOLOGY (2015)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis et al.
BRAIN PATHOLOGY (2014)
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations
M. Labussiere et al.
BRITISH JOURNAL OF CANCER (2014)
Extracellular Vesicles Modulate the Glioblastoma Microenvironment via a Tumor Suppression Signaling Network Directed by miR-1
Agnieszka Bronisz et al.
CANCER RESEARCH (2014)
Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
Kelly M. MacArthur et al.
CANCER RESEARCH (2014)
Developing Precision Medicine in a Global World
Eric H. Rubin et al.
CLINICAL CANCER RESEARCH (2014)
Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic Cholangiocarcinoma
Darrell R. Borger et al.
CLINICAL CANCER RESEARCH (2014)
Serum 2-Hydroxyglutarate Production in IDH1- and IDH2-Mutated De Novo Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association Group
Maxime Janin et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Benefit From Procarbazine, Lomustine, and Vincristine in Oligodendroglial Tumors Is Associated With Mutation of IDH
J. Gregory Cairncross et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Efficacy of erlotinib in patients with relapsed gliobastoma multiforme who expressed EGFRVIII and PTEN determined by immunohistochemistry
Oscar Gallego et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
MGMT promoter methylation in plasma of glioma patients receiving temozolomide
Valentina Fiano et al.
JOURNAL OF NEURO-ONCOLOGY (2014)
Using the molecular classification of glioblastoma to inform personalized treatment
Adriana Olar et al.
JOURNAL OF PATHOLOGY (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Circulating MicroRNA Biomarkers for Glioma and Predicting Response to Therapy
Charlotte A. Tumilson et al.
MOLECULAR NEUROBIOLOGY (2014)
An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage
Aaron M. Newman et al.
NATURE MEDICINE (2014)
Molecular analysis of circulating tumour cells-biology and biomarkers
Matthew G. Krebs et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Association of matrix metalloproteinase 2 plasma level with response and survival in patients treated with bevacizumab for recurrent high-grade glioma
Emeline Tabouret et al.
NEURO-ONCOLOGY (2014)
Invasion and proliferation kinetics in enhancing gliomas predict IDH1 mutation status
Anne L. Baldock et al.
NEURO-ONCOLOGY (2014)
Targeted molecular therapies against epidermal growth factor receptor: Past experiences and challenges
David A. Reardon et al.
NEURO-ONCOLOGY (2014)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2007-2011
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2014)
Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
David A. Nathanson et al.
SCIENCE (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Hematogenous dissemination of glioblastoma multiforme
Carolin Mueller et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
EGFR Variant Heterogeneity in Glioblastoma Resolved through Single-Nucleus Sequencing
Joshua M. Francis et al.
CANCER DISCOVERY (2014)
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
James P. Sullivan et al.
CANCER DISCOVERY (2014)
Blood-Based Analyses of Cancer: Circulating Tumor Cells and Circulating Tumor DNA
Daniel A. Haber et al.
CANCER DISCOVERY (2014)
Emerging Therapies for Glioblastoma
Alissa A. Thomas et al.
JAMA NEUROLOGY (2014)
Principles and methods of integrative genomic analyses in cancer
Vessela N. Kristensen et al.
NATURE REVIEWS CANCER (2014)
Circulating biomarkers of CNS tumors: an update
Ayseguel Ilhan-Mutlu et al.
BIOMARKERS IN MEDICINE (2013)
Serum 2-hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia
Courtney D. DiNardo et al.
BLOOD (2013)
The Somatic Genomic Landscape of Glioblastoma
Cameron W. Brennan et al.
CELL (2013)
Cancer Genome Scanning in Plasma: Detection of Tumor-Associated Copy Number Aberrations, Single-Nucleotide Variants, and Tumoral Heterogeneity by Massively Parallel Sequencing
K. C. Allen Chan et al.
CLINICAL CHEMISTRY (2013)
Circulating Tumor Cells: Liquid Biopsy of Cancer
Catherine Alix-Panabieres et al.
CLINICAL CHEMISTRY (2013)
Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
Cuihua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Detection of MGMT, RASSF1A, p15INK4B, and p14ARF promoter methylation in circulating tumor-derived DNA of central nervous system cancer patients
Aleksandra Majchrzak-Celinska et al.
JOURNAL OF APPLIED GENETICS (2013)
Blood-based biomarkers for malignant gliomas
Matthias Holdhoff et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients
Mohamad A. Salkeni et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion
Heidi G. Moller et al.
MOLECULAR NEUROBIOLOGY (2013)
The causes and consequences of genetic heterogeneity in cancer evolution
Rebecca A. Burrell et al.
NATURE (2013)
Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay
Irene Baccelli et al.
NATURE BIOTECHNOLOGY (2013)
The integrated landscape of driver genomic alterations in glioblastoma
Veronique Frattini et al.
NATURE GENETICS (2013)
Liquid biopsy: monitoring cancer-genetics in the blood
Emily Crowley et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Cytokine Patterns in Brain Tumour Progression
Radu Albulescu et al.
MEDIATORS OF INFLAMMATION (2013)
Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation
Wolfgang Wick et al.
NEUROLOGY (2013)
Exploratory investigation of eight circulating plasma markers in brain tumor patients
Aysegul Ilhan-Mutlu et al.
NEUROSURGICAL REVIEW (2013)
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Sarah-Jane Dawson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development
Johnny C. Akers et al.
PLOS ONE (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Osteopontin and splice variant expression level in human malignant glioma: Radiobiologic effects and prognosis after radiotherapy
Antje Guettler et al.
RADIOTHERAPY AND ONCOLOGY (2013)
An Inhibitor of Mutant IDH1 Delays Growth and Promotes Differentiation of Glioma Cells
Dan Rohle et al.
SCIENCE (2013)
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Rob A. Cairns et al.
CANCER DISCOVERY (2013)
Circulating tumor cells and DNA as liquid biopsies
Ellen Heitzer et al.
GENOME MEDICINE (2013)
BEAMing and Droplet Digital PCR Analysis of Mutant IDH1 mRNA in Glioma Patient Serum and Cerebrospinal Fluid Extracellular Vesicles
Walter W. Chen et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
Prospective serial evaluation of 2-hydroxyglutarate, during treatment of newly diagnosed acute myeloid leukemia, to assess disease activity and therapeutic response
Amir T. Fathi et al.
BLOOD (2012)
RNA expression patterns in serum microvesicles from patients with glioblastoma multiforme and controls
Mikkel Noerholm et al.
BMC CANCER (2012)
Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients
Ayseguel Ilhan-Mutlu et al.
CANCER INVESTIGATION (2012)
Receptor Tyrosine Kinase Genes Amplified in Glioblastoma Exhibit a Mutual Exclusivity in Variable Proportions Reflective of Individual Tumor Heterogeneity
Suzanne E. Little et al.
CANCER RESEARCH (2012)
2-Hydroxyglutarate concentration in serum from patients with gliomas does not correlate with IDH1/2 mutation status or tumor size
David Capper et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Plasma specific miRNAs as predictive biomarkers for diagnosis and prognosis of glioma
Qiong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2012)
Serum YKL-40 following resection for cerebral glioblastoma
Daniela Bernardi et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Decrease in circulating endothelial progenitor cells in treated glioma patients
Elena Corsini et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas
Hatim Husain et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
2-hydroxyglutarate detection by magnetic resonance spectroscopy in subjects with IDH-mutated gliomas
Changho Choi et al.
NATURE MEDICINE (2012)
Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma
Prakash Chinnaiyan et al.
NEURO-ONCOLOGY (2012)
Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma
Alexander Baraniskin et al.
NEURO-ONCOLOGY (2012)
Patterns of care and survival for patients with glioblastoma multiforme diagnosed during 2006
K. Robin Yabroff et al.
NEURO-ONCOLOGY (2012)
Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma
Elana S. Tykocinski et al.
NEURO-ONCOLOGY (2012)
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity
Nadiya M. Teplyuk et al.
NEURO-ONCOLOGY (2012)
A population-based study on the effect of temozolomide in the treatment of glioblastoma multiforme
Pal A. Ronning et al.
NEURO-ONCOLOGY (2012)
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practice
Michael Weller et al.
NEURO-ONCOLOGY (2012)
Detection of IDH1 mutation in the plasma of patients with glioma
Blandine Boisselier et al.
NEUROLOGY (2012)
Clonal Analysis in Recurrent Astrocytic, Oligoastrocytic and Oligodendroglial Tumors Implicates IDH1- Mutation as Common Tumor Initiating Event
Ulrike Lass et al.
PLOS ONE (2012)
Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
Tim Forshew et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Intratumor Heterogeneity: Seeing the Wood for the Trees
Timothy A. Yap et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Current Concepts and Management of Glioblastoma
Matthias Preusser et al.
ANNALS OF NEUROLOGY (2011)
Blood platelets contain tumor-derived RNA biomarkers
R. Jonas A. Nilsson et al.
BLOOD (2011)
Neurospecific Proteins in the Serum of Patients with Brain Tumors
N. V. Lyubimova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
Matija Snuderl et al.
CANCER CELL (2011)
Tumour and serum MGMT promoter methylation and protein expression in glioblastoma patients
Carmen Balana et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2011)
Myeloid Biomarkers Associated with Glioblastoma Response to Anti-VEGF Therapy with Aflibercept
John F. de Groot et al.
CLINICAL CANCER RESEARCH (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Rare Phenomenon of Extracranial Metastasis of Glioblastoma
Ekokobe Fonkem et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma
Gaspar Reynes et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Phase I trial with biomarker studies of vatalanib (PTK787) in patients with newly diagnosed glioblastoma treated with enzyme inducing anti-epileptic drugs and standard radiation and temozolomide
Elizabeth R. Gerstner et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A specific miRNA signature in the peripheral blood of glioblastoma patients
Patrick Roth et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Serum angiogenic profile of patients with glioblastoma identifies distinct tumor subtypes and shows that TIMP-1 is a prognostic factor
Matthew Crocker et al.
NEURO-ONCOLOGY (2011)
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2011)
Extra-Neural Metastases of Malignant Gliomas: Myth or Reality?
Patrick Beauchesne
Cancers (2011)
Cell-free nucleic acids as biomarkers in cancer patients
Heidi Schwarzenbach et al.
NATURE REVIEWS CANCER (2011)
Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
Houtan Noushmehr et al.
CANCER CELL (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Identification of Potential Serum Biomarkers of Glioblastoma: Serum Osteopontin Levels Correlate with Poor Prognosis
Peddagangannagari Sreekanthreddy et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme
M. U. Schuhmann et al.
EJSO (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Circulating endothelial progenitor cells in malignant gliomas Clinical article
Neysan Rafat et al.
JOURNAL OF NEUROSURGERY (2010)
Microfluidic isolation and transcriptome analysis of serum microvesicles
Chihchen Chen et al.
LAB ON A CHIP (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Quantitative detection of multiple gene promoter hypermethylation in tumor tissue, serum, and cerebrospinal fluid predicts prognosis of malignant gliomas
Bo-Lin Liu et al.
NEURO-ONCOLOGY (2010)
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
C. Houillier et al.
NEUROLOGY (2010)
Plasma proteome profiling reveals biomarker patterns associated with prognosis and therapy selection in glioblastoma multiforme patients
Anders Carlsson et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
Rebecca J. Leary et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working Group
Steven M. Teutsch et al.
GENETICS IN MEDICINE (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
P16 PROMOTER METHYLATION IN THE SERUM AS A BASIS FOR THE MOLECULAR DIAGNOSIS OF GLIOMAS
Toshihiko Wakabayashi et al.
NEUROSURGERY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
Xi Chen et al.
CELL RESEARCH (2008)
Correlation of O6-Methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity
Monika E. Hegi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas
Dieto Brandsma et al.
LANCET ONCOLOGY (2008)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells
Khalid Al-Nedawi et al.
NATURE CELL BIOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Circulating mutant DNA to assess tumor dynamics
Frank Diehl et al.
NATURE MEDICINE (2008)
Phase II study of temozolomide, thalidomide, and celecoxib for newly diagnosed glioblastoma in adults
Santosh Kesari et al.
NEURO-ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
An integrated genomic analysis of human glioblastoma Multiforme
D. Williams Parsons et al.
SCIENCE (2008)
Detection, clinical relevance and specific biological properties of disseminating tumour cells
Klaus Pantel et al.
NATURE REVIEWS CANCER (2008)
Serum GFAP is a diagnostic marker for glioblastoma multiforme
C. S. Jung et al.
BRAIN (2007)
Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas
T. Brommeland et al.
ACTA NEUROLOGICA SCANDINAVICA (2007)
A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme
Morris D. Groves et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Alteration of serum and tumoral neural cell adhesion molecule (NCAM) isoforms in patients with brain tumors
Laura Todaro et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas
Adilia Hormigo et al.
CLINICAL CANCER RESEARCH (2006)
Increased concentrations of transforming growth factor β1 and β2 in the plasma of patients with glioblastoma
Thomas Schneider et al.
JOURNAL OF NEURO-ONCOLOGY (2006)
Oncomirs - microRNAs with a role in cancer
A Esquela-Kerscher et al.
NATURE REVIEWS CANCER (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Serum glial fibrillary acidic protein as a biomarker for intracerebral haemorrhage in patients with acute stroke
C Foerch et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2006)
Methylated tumor-specific DNA as a plasma biomarker in patients with glioma
KD Weaver et al.
CANCER INVESTIGATION (2006)
Biomarkers in cancer staging, prognosis and treatment selection
JA Ludwig et al.
NATURE REVIEWS CANCER (2005)
Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: Tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01
AB Lassman et al.
CLINICAL CANCER RESEARCH (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Transmission of glioblastoma multiforme following bilateral lung transplantation from an affected donor: Case study and review of the literature
MY Armanios et al.
NEURO-ONCOLOGY (2004)
Glial fibrillary acidic protein injury and multiple trauma in serum after traumatic brain
LE Pelinka et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2004)
No evidence of tumour cells in blood of patients with glioma
C Böhm et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2003)
Serum s100β -: A noninvasive marker of blood-brain barrier function and brain lesions
AA Kanner et al.
CANCER (2003)
Metastasis to and from the central nervous system - the 'relatively protected site'
A Subramanian et al.
LANCET ONCOLOGY (2002)
About the possible origin and mechanism of circulating DNA - Apoptosis and active DNA release
M Stroun et al.
CLINICA CHIMICA ACTA (2001)
Distinct expression patterns and levels of enzymatic activity of matrix metalloproteinases and their inhibitors in primary brain tumors
A Pagenstecher et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2001)
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
HA Fine et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
